Breast cancer incidence trends in Golestan, Iran: An age-period-cohort analysis by ethnic region, 2004-2018

Ghasemi-Kebria, Fatemeh; Fazel, Abdolreza; Semnani, Shahryar; Etemadi, Arash; Naeimi-Tabiei, Mohammad; Hasanpour-Heidari, Susan; Salamat, Faezeh; Jafari-Delouie, Nastaran; Sedaghat, SeyedMehdi; Sadeghzadeh, Hamideh; Akbari, Mahnaz; Mehrjerdian, Mahshid; Weiderpass, Elisabete; Roshandel, Gholamreza; Bray, Freddie; Malekzadeh, Reza

doi:10.1016/j.canep.2024.102525

Cited by 1 publication

(1 citation statement)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In many high-income countries where breast cancer incidence rates are historically high, mortality rates decreased since around the early 1990s, 49 reflecting progress because of numerous treatment breakthroughs and improvements in early detection by screening and heightened breast cancer awareness. In contrast, rapid increases in breast cancer incidence and mortality are seen in transitioning countries in South America, Africa, and Asia [50][51][52][53][54] as well as in high-income Asian countries (Japan and the Republic of Korea). 55 There remain substantial geographic and temporal variations in breast cancer mortality in different regions 54,56 that appear to be linked to the level of coverage of essential health services.…”

Section: Malesmentioning

confidence: 97%

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Bray,

Laversanne,

Sung

et al. 2024

CA A Cancer J Clinicians

Self Cite

973

View full text Add to dashboard Cite

This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers [NMSCs]) alongside 9.7 million deaths from cancer (including NMSC). The estimates suggest that approximately one in five men or women develop cancer in a lifetime, whereas around one in nine men and one in 12 women die from it. Lung cancer was the most frequently diagnosed cancer in 2022, responsible for almost 2.5 million new cases, or one in eight cancers worldwide (12.4% of all cancers globally), followed by cancers of the female breast (11.6%), colorectum (9.6%), prostate (7.3%), and stomach (4.9%). Lung cancer was also the leading cause of cancer death, with an estimated 1.8 million deaths (18.7%), followed by colorectal (9.3%), liver (7.8%), female breast (6.9%), and stomach (6.8%) cancers. Breast cancer and lung cancer were the most frequent cancers in women and men, respectively (both cases and deaths). Incidence rates (including NMSC) varied from four‐fold to five‐fold across world regions, from over 500 in Australia/New Zealand (507.9 per 100,000) to under 100 in Western Africa (97.1 per 100,000) among men, and from over 400 in Australia/New Zealand (410.5 per 100,000) to close to 100 in South‐Central Asia (103.3 per 100,000) among women. The authors examine the geographic variability across 20 world regions for the 10 leading cancer types, discussing recent trends, the underlying determinants, and the prospects for global cancer prevention and control. With demographics‐based predictions indicating that the number of new cases of cancer will reach 35 million by 2050, investments in prevention, including the targeting of key risk factors for cancer (including smoking, overweight and obesity, and infection), could avert millions of future cancer diagnoses and save many lives worldwide, bringing huge economic as well as societal dividends to countries over the forthcoming decades.

show abstract